Literature DB >> 27280422

Identification and Antifungal Susceptibility of Penicillium-Like Fungi from Clinical Samples in the United States.

Marcela Guevara-Suarez1, Deanna A Sutton2, José F Cano-Lira3, Dania García1, Adela Martin-Vicente1, Nathan Wiederhold2, Josep Guarro1, Josepa Gené1.   

Abstract

Penicillium species are some of the most common fungi observed worldwide and have an important economic impact as well as being occasional agents of human and animal mycoses. A total of 118 isolates thought to belong to the genus Penicillium based on morphological features were obtained from the Fungus Testing Laboratory at the University of Texas Health Science Center in San Antonio (United States). The isolates were studied phenotypically using standard growth conditions. Molecular identification was made using two genetic markers, the internal transcribed spacer (ITS) and a fragment of the β-tubulin gene. In order to assess phylogenetic relationships, maximum likelihood and Bayesian inference assessments were used. Antifungal susceptibility testing was performed according to CLSI document M38-A2 for nine antifungal drugs. The isolates were identified within three genera, i.e., Penicillium, Talaromyces, and Rasamsonia The most frequent species in our study were Penicillium rubens, P. citrinum, and Talaromyces amestolkiae The potent in vitro activity of amphotericin B (AMB) and terbinafine (TRB) and of the echinocandins against Penicillium and Talaromyces species might offer a good therapeutic alternative for the treatment of infections caused by these fungi.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27280422      PMCID: PMC4963513          DOI: 10.1128/JCM.00960-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  37 in total

1.  Epidemiology of invasive respiratory disease caused by emerging non-Aspergillus molds in lung transplant recipients.

Authors:  M Peghin; V Monforte; M T Martin-Gomez; I Ruiz-Camps; C Berastegui; B Saez; J Riera; J Solé; J Gavaldá; A Roman
Journal:  Transpl Infect Dis       Date:  2016-02-03       Impact factor: 2.228

2.  Disseminated Geosmithia argillacea infection in a patient with gastrointestinal GvHD.

Authors:  T Valentin; P Neumeister; M Pichler; A Rohn; C Koidl; D Haas; B Heiling; M Asslaber; I Zollner-Schwetz; M Hoenigl; H J F Salzer; R Krause; W Buzina
Journal:  Bone Marrow Transplant       Date:  2011-07-25       Impact factor: 5.483

3.  Identification and nomenclature of the genus Penicillium.

Authors:  C M Visagie; J Houbraken; J C Frisvad; S-B Hong; C H W Klaassen; G Perrone; K A Seifert; J Varga; T Yaguchi; R A Samson
Journal:  Stud Mycol       Date:  2014-06       Impact factor: 16.097

4.  Travel-related disseminated Penicillium marneffei infection in a renal transplant patient.

Authors:  J Hart; J R Dyer; B M Clark; D G McLellan; S Perera; P Ferrari
Journal:  Transpl Infect Dis       Date:  2011-12-20       Impact factor: 2.228

5.  Taxonomy and antifungal susceptibility of clinically important Rasamsonia species.

Authors:  J Houbraken; S Giraud; M Meijer; S Bertout; J C Frisvad; J F Meis; J P Bouchara; R A Samson
Journal:  J Clin Microbiol       Date:  2012-10-17       Impact factor: 5.948

6.  High diversity of non-sporulating moulds in respiratory specimens of immunocompromised patients: should all the species be reported when diagnosing invasive aspergillosis?

Authors:  Dea Garcia-Hermoso; Alexandre Alanio; Odile Cabaret; Martine Olivi; Françoise Foulet; Catherine Cordonnier; Jean-Marc Costa; Stéphane Bretagne
Journal:  Mycoses       Date:  2015-07-27       Impact factor: 4.377

7.  Penicillium marneffei infection: an emerging disease in mainland China.

Authors:  Yongxuan Hu; Junmin Zhang; Xiqing Li; Yabo Yang; Yong Zhang; Jianchi Ma; Liyan Xi
Journal:  Mycopathologia       Date:  2012-09-17       Impact factor: 2.574

Review 8.  In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.

Authors:  A Espinel-Ingroff; K Boyle; D J Sheehan
Journal:  Mycopathologia       Date:  2001       Impact factor: 3.785

9.  Voriconazole-Resistant Penicillium oxalicum: An Emerging Pathogen in Immunocompromised Hosts.

Authors:  Anuradha Chowdhary; Shallu Kathuria; Kshitij Agarwal; Neelam Sachdeva; Pradeep K Singh; Sandeep Jain; Jacques F Meis
Journal:  Open Forum Infect Dis       Date:  2014-08-16       Impact factor: 3.835

10.  Delimitation and characterisation of Talaromyces purpurogenus and related species.

Authors:  N Yilmaz; J Houbraken; E S Hoekstra; J C Frisvad; C M Visagie; R A Samson
Journal:  Persoonia       Date:  2012-11-12       Impact factor: 11.051

View more
  12 in total

1.  Isolation and Identification of Penicillium rubens from the Local Strain in Mosul, Iraq, and Investigation of Potassium Phosphate Effect on its Growth.

Authors:  M Yahya Allawi; B Salim Al-Taie; R M Hmoshi
Journal:  Arch Razi Inst       Date:  2022-02-28

2.  Recognition of Diagnostic Gaps for Laboratory Diagnosis of Fungal Diseases: Expert Opinion from the Fungal Diagnostics Laboratories Consortium (FDLC).

Authors:  Sean X Zhang; N Esther Babady; Kimberly E Hanson; Amanda T Harrington; Paige M K Larkin; Sixto M Leal; Paul M Luethy; Isabella W Martin; Preeti Pancholi; Gary W Procop; Stefan Riedel; Seyedmojtaba Seyedmousavi; Kaede V Sullivan; Thomas J Walsh; Shawn R Lockhart
Journal:  J Clin Microbiol       Date:  2021-06-18       Impact factor: 5.948

3.  Penicillium citrinum: Opportunistic pathogen or idle bystander? A case analysis with demonstration of galactomannan cross-reactivity.

Authors:  Shayla E Hesse; Paul M Luethy; John H Beigel; Adrian M Zelazny
Journal:  Med Mycol Case Rep       Date:  2017-05-22

4.  Successful treatment of pulmonary invasive fungal infection by Penicillium non-marneffei in lymphoblastic lymphoma: case report and literature review.

Authors:  Isabel Ramírez; Alicia Hidrón; Ricardo Cardona
Journal:  Clin Case Rep       Date:  2018-05-02

Review 5.  A case report of fungal infection associated acute fibrinous and organizing pneumonitis.

Authors:  Jiangnan Zhao; Yi Shi; Dongmei Yuan; Qunli Shi; Weiping Wang; Xin Su
Journal:  BMC Pulm Med       Date:  2020-04-20       Impact factor: 3.317

6.  Diversity, Co-occurrence and Implications of Fungal Communities in Wastewater Treatment Plants.

Authors:  Hailemariam Abrha Assress; Ramganesh Selvarajan; Hlengilizwe Nyoni; Khayalethu Ntushelo; Bhekie B Mamba; Titus A M Msagati
Journal:  Sci Rep       Date:  2019-10-01       Impact factor: 4.379

7.  Performance Evaluation of VITEK MS for the Identification of a Wide Spectrum of Clinically Relevant Filamentous Fungi Using a Korean Collection.

Authors:  Ju Hyeon Shin; Soo Hyun Kim; Dain Lee; Seung Yeob Lee; Sejong Chun; Jun Hyung Lee; Eun Jeong Won; Hyun Jung Choi; Hyun Woo Choi; Seung Jung Kee; Myung Geun Shin; Jong Hee Shin
Journal:  Ann Lab Med       Date:  2021-03-01       Impact factor: 3.464

8.  First Reported Case of Invasive Cutaneous Penicillium cluniae Infection in a Patient With Acute Myelogenous Leukemia: A Case Report and Literature Review.

Authors:  Devanshi Mehta; Samuel A Hofacker; Julian A Villalba; Lyn M Duncan; John A Branda; Connie Cañete-Gibas; Nathan Wiederhold; Jenna Moran; Amir T Fathi; Steven T Chen; Jessica Cervantes; Sarah P Hammond
Journal:  Open Forum Infect Dis       Date:  2021-05-23       Impact factor: 3.835

Review 9.  Taxonomy and evolution of Aspergillus, Penicillium and Talaromyces in the omics era - Past, present and future.

Authors:  Chi-Ching Tsang; James Y M Tang; Susanna K P Lau; Patrick C Y Woo
Journal:  Comput Struct Biotechnol J       Date:  2018-05-31       Impact factor: 7.271

10.  Eye Infections Caused by Filamentous Fungi: Spectrum and Antifungal Susceptibility of the Prevailing Agents in Germany.

Authors:  Grit Walther; Anna Zimmermann; Johanna Theuersbacher; Kerstin Kaerger; Marie von Lilienfeld-Toal; Mathias Roth; Daniel Kampik; Gerd Geerling; Oliver Kurzai
Journal:  J Fungi (Basel)       Date:  2021-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.